(ANSAmed) - TEL AVIV, JANUARY 13 - A research in Israel on
the results obtained after the first dose of the Pfizer vaccine
is encouraging, according to the newspaper Yediot Ahronot. The
daily reported about the research conducted by the country's
main welfare agency Clalit on 200,000 people aged over 60 who
received the first dose.
Compared with another 200,000 people who were not vaccinated, over an initial period of 12 days the two groups showed the same characteristics. But starting on the 13th day onwards the number of new infections among those who received the first shot dropped by 33% compared to the other group. The first inoculation appeared to have reduced the risk of contagion in that age group, according to preliminary data, the newspaper said.
The research will continue over the next weeks among those who have in the meantime received the second dose, which according to Pfizer is the key one for immunization. (ANSAmed).
Compared with another 200,000 people who were not vaccinated, over an initial period of 12 days the two groups showed the same characteristics. But starting on the 13th day onwards the number of new infections among those who received the first shot dropped by 33% compared to the other group. The first inoculation appeared to have reduced the risk of contagion in that age group, according to preliminary data, the newspaper said.
The research will continue over the next weeks among those who have in the meantime received the second dose, which according to Pfizer is the key one for immunization. (ANSAmed).
